surgical robots

The US Food and Drug Administration has released draft guidance for surgical robots, setting out proposed recommendations for devices used in robotic-assisted surgery. The guidance, reported by MedTech Dive, gives manufacturers and healthcare providers a framework to review. Stakeholders can weigh in before the agency finalizes its position.

The US Food and Drug Administration has issued draft guidance for cardiovascular surgical robots, outlining the agency's current thinking on the development and review of robotic systems used in cardiac and vascular procedures. The document gives manufacturers and clinicians a framework to follow, and a public comment period typically allows stakeholders to give feedback before the guidance is finalized.